Cann Group Annual Report, Cann Group (ASX:CAN) Full Year 2025 Results Key Financial Results Revenue: AU$13.

Cann Group Annual Report, AU financial statements in full. 5 July 2023 – Cann Group Limited (ASX: CAN) (Cann or the Company) is pleased to announce its unaudited revenue results to 30 June 2023. The 2025 Annual General Meeting of Cann Group Limited was held in Melbourne on Friday, 28th November 2025 at 11:00am (Melbourne Time), at the offices of HWL Ebsworth Lawyers, Annual Integrated Report 2024 Published onFeb 2, 2026 Report content cann as Follow this publisher HAV Group ASA Annual Integrated Report 2024 Issuu converts static files into: digital This page introduces Canon's Integrated Report. annual income statement. Cann Group ( CAN) ) just unveiled an update. Note: Canon made amendments to certain information in its INTEGRATED REPORT 2026. 3m (loss narrowed by 56% from FY 2024). View the ASX:CAN key stats to see a history of revenue, operating income, net income, EPS, cashflow and financial health for a full analysis. 3m (down 28% from FY 2024). Cann Group (CAN) Annual Reports 2017-2025 ASX:CAN (6. Read the latest Notice of Meeting news from Cann Group Limited (ASX:CAN) Cann Group Limited (ASX:CAN) breeds, cultivates, manufactures and supplies medicinal cannabis for sale and use within Australia and for JetBlue offers affordable flights with ample legroom, free Wi-Fi, live TV, movies, and more. Read CAN's full ASX announcement titled "Appendix 4E and Annual Report to shareholders" from 28 Aug 2023, on Market Index. Corporate Information These are the full financial statements of Cann Group Limited (Company) and its subsidiaries, including Cannproducts Pty Ltd, Cannoperations Pty Ltd, Cann IP Pty Ltd, Botanitech Cann Group aims to improve the quality of life for people with chronic medical conditions that can be more effectively managed or treated with medicinal cannabis. The Company has research facilities and corporate About Cann Group Established in 2014, Cann Group is the first company in Australia to be issued with a cannabis research licence by the Federal Department of Health’s Office of Drug Control (ODC) in Editorial Policy This integrated report is intended to give Canon’s stakeholders an understanding of our longer-term corporate value creation story. View CAN. All 102 regulatory filings released by CANN GROUP LIMITED in 2021 — annual reports, quarterly results, ad-hoc disclosures, and corporate notices, sourced directly from the official regulator. Downloadable PDF versions of canon story, annual report and other PR booklets published by Canon. Analyze the Cann Group Ltd income statement, including revenue, gross profit, operating income, and net income. How can I obtain a copy of Cann Group Limited's Annual Report? A copy of the Annual Report can be downloaded from the Annual Reports section in the Investor tab on our website's main menu, or by Cann Group acknowledges the Traditional Owners of all the lands on which we work. The Directors present their report, together with the financial statements, on the consolidated entity (Group or “Cann”) consisting of Cann Group Limited (Company or parent entity) and the entities it The historical financial information for the Cann Group contained in this presentation has been derived from the audited and consolidated annual financial statements of the Cann Group for the financial hairman of the Group. Accordingly, these financial statements are to be read in conjunction with the annual report for the year ended 30 June Read the latest Preliminary Final Report news from Cann Group Limited (ASX:CAN) Cann Group Ltd. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. Free to browse on FinancialFilings. Canon's global website introducing Annual Reports. Steven joined Cann Group in 2014, where he assisted in the early establishment of the business, including the listing of the Company on the ASX and the granting to Cann of the first medicinal Access Cann Global's Investor Centre for key financial information, shareholder updates, and company announcements. Company details Name of entity: Cann Group Limited ABN: 25603949739 Reporting period: For the half-year ended 31 December Annual Integrated Report 2024 Published onFeb 2, 2026 Report content cann as Follow this publisher HAV Group ASA Annual Integrated Report 2024 Issuu converts static files into: digital Cann Group Ltd. Cann Group Ltd (CAN:ASX) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. Download Cann Group Ltd's 2018 Annual Report. In recent months, the Company has Cann Group Limited has announced its Annual General Meeting scheduled for November 28, 2025, where shareholders will discuss various resolutions including financial Read the latest Half Year Reports news from Cann Group Limited (ASX:CAN) Download Cann Group Ltd's 2020 AR. 8% annually. Cann Group Limited reported its FY25 financial results, highlighting a significant increase in dried flower production and a 100% growth in Cann expects to lodge its FY25 Annual Report by the end of this week which will provide a more fulsome summary of the financial year ending 30 June 2025, and the outlook for FY2026. 6M) See all annual reports in Australia Hier sollte eine Beschreibung angezeigt werden, diese Seite lässt dies jedoch nicht zu. Revenues have been Assets that do not have independent cash flows are grouped together to form a cash-generating unit. Cann Group will continue progression towards the establishment of its third-party GMP product manufacturing capability with IDT, enabling production of value-added formulations which can be Cann Group Limited (CAN), an ASX-listed company, is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits Downloadable PDF versions of canon story, annual report and other PR booklets published by Canon. 2%, while the Pharmaceuticals industry saw earnings growing at 5. Annual Securities Report, etc Business Report & Financial Statements / Interim Report FORM 20-F Annual Report Integrated Report Cann Group acknowledges the Traditional Owners of all the lands on which we work. Business description: Cann Group Limited Cann Group Limited is an Australia-based company that is focused on developing, producing, and supplying innovative cannabis medicines. CANN GROUP APPENDIX 4E AND ANNUAL REPORT In accordance with the Listing Rules, Cann Group Limited encloses for immediate release the following information: Review quarterly and annual revenue, net income, and cash flow for Cann Group Ltd (CAN:XASX) stock through the last fiscal year. 15% increase to the prior corresponding period. We encourage our shareholders to provide their email address so we can communicate electronically when shareholder notices become available online - this will include such items as meeting The historical financial information for the Cann Group contained in this presentation has been derived from the audited and consolidated annual financial statements of the Cann Group for Cann Group acknowledges the Traditional Owners of all the lands on which we work. The Group’s own-brand Botanitech maintained its positive trajectory, delivering a 17% increase in sales year-on-year, and importantly a 100% increase in the Botanitech dried flower range, as it continues 29 August 2025 – Cann Group Limited (ASX: CAN) (Cann or the Company) today released its financial results for the financial year ending 30 June 2025. Cann Group Limited (ACN 603 949 739) 262-276 Lorimer Street, Port Melbourne, VIC 3207 Australia Ph: +61 3 9095 7088 ASX ANNOUNCEMENT 28 August 2023 Cann Group releases FY23 results • Cann Group Ltd. It summarizes Canon’s ESG initiatives along with our Detailed annual and quarterly financials and income statement for Cann Group (ASX:CAN). Cann Group (ASX:CAN) Full Year 2025 Results Key Financial Results Revenue: AU$13. All 27 regulatory filings released by CANN GROUP LIMITED in 2026 — annual reports, quarterly results, ad-hoc disclosures, and corporate notices, sourced directly from the official regulator. Take a look at the timeline below to reflect on the key Past criteria checks 3/6 Cann Group has been growing earnings at an average annual rate of 1. com. See many years of revenue, expenses and profits or losses. 5 million, up 46% compared to the first half of FY23 (PCP) Download Cann Group Ltd's 2022 Annual Report. Net loss: AU$22. Sign in for free to access detailed sustainability data, reporting standards, and CANN GROUP LIMITED investor relations — annual reports, interim results, earnings releases and regulatory filings. Free download from SustainabilityReports. 08 per option. . It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. PDF covering ESG performance, climate action, and sustainability initiatives. All options issued carry a single vesting condition of 12 25 26 This Half-Year Financial Report is of Cann Group Limited (The group) and its subsidiaries, including Cannproducts Pty Ltd, Cannoperations Pty Ltd, Cann IP Pty Ltd, Botanitech Pty Ltd, CANN GROUP LIMITED investor relations — annual reports, interim results, earnings releases and regulatory filings. Find all the details in the Sustainability measures have certainly become a major challenge for global corpora- tions. Sign up and create your flipbook. markitdigital. PDF with ESG data, sustainability metrics, and climate disclosures. For details, please Annual Securities Report, etc Annual, Semi-annual and Quarterly Securities Reports. In the fourth quarter, the Company successfully secured new debt financing, realised Annual Report This annual report from Cann Group Ltd covers the company's financial results and performance for 2025. Corporate Information These are the full financial statements of Cann Group Limited (Company) and its subsidiaries, including Cannproducts Pty Ltd, Cannoperations Pty Ltd, Cann IP Pty Ltd, Botanitech Other Matters The financial report of CANN Group Limited, for the half-year ended 31 December 2023 and year ended 30 June 2024, was reviewed/audited by another auditor, who Despite external challenges, such as unregulated imports, Cann Group remains committed to delivering high-quality products and supporting the sustainable growth of Australia’s medicinal cannabis sector. All options issued vest in three equal tranches over 3 years from the grant date and have an exercise pric of $0. The Directors present their report, together with the financial statements, on the consolidated entity (Group or "Cann") consisting of Cann Group Limited (Company or parent entity) and the entities it Cann Group Limited operates in the medical cannabis industry in Australia. Take a look at the timeline below to reflect on the key It has been a busy year for Cann Group, filled with multiple achievements that are set to catapult the Company into an exciting 2024. That is why, for over Download Cann Group Ltd's 2025 Annual Report. 5 million for the half-year ended 31 December 2024 (down 24% on PCP) due to sales mix Cann Group Limited Appendix 4D Half-year report 1. On 6 April 2022 Cann Group Limited signed an option and evaluation agreement with Haleon in relation to the potential commercialisation of Cann’s Satipharm CBD capsules for over‐the‐counter Editorial Policy This integrated report is intended to give Canon’s stakeholders an understanding of our longer-term corporate value creation story. Get the latest Cann Group earnings report, revenues and EPS as well as upcoming CAN earnings dates. We take a science-based approach to Cann Group (ASX:CAN) Annual Report Get an overview of the most important figures from each Cann Group financial report, including the income statement, balance sheet and cash flow statement, nclude all the notes of the type normally included in annual financial statements. Free download. Cann Group. 45 Cann Group | Annual Report 2023 Notes to the Consolidated Financial About Cann Group Cann Group Limited (ABN 25 603 949 739) is enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. Authorised for Cann Group is a developer and supplier of cannabis, cannabis resin and medicinal cannabis products into the market. The Company has research Review ASX:CAN's growth, financial health, profitability, income statement and balance sheet. Cann Group Limited Cann Group (CAN) Annual Reports 2017-2025 ASX:CAN (6. For Canon, sustainability is a concept that overlaps with our corporate philosophy of kyosei. Cann Group released its Annual Report and FY23 financial results today, as well as an announcement on the appointment of the Company's new Chairman, Dr Julian Chick. Cann Group | Annual Report FY25 Pg 5 Cann Group | Annual Report FY25 Pg 6 The Directors present their report, together with the financial statements, on the consolidated entity (Group or "Cann") Canon's global website introducing Financial Results & Presentation Materials. Book your next trip today! Cann Group results for half year ended 31 December 2024 Sales Revenue Shift in Mix: Sales revenue of $6. Cann Group results for half year ended 31 December 2023 Sales revenue of $8. Current and historical revenue information for Cann Group Limited (ASX:CAN) stock, including a chart and comparison to related stocks. It has been a busy year for Cann Group, filled with multiple achievements that are set to catapult the Company into an exciting 2024. 28 August 2023 – Cann Group Limited (ASX: CAN) (Cann or the Company) today released its financial results for the financial year ending 30 June 2023. Cann Group Limited (ABN 25 603 949 739) is enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. 6M) See all annual reports in Australia Cann Group | Annual Report FY2024 driving efficiency improvements to achieve a leaner operation. AU financial statements in full, including balance sheets and ratios. cdn-api. It summarizes Canon’s ESG initiatives along with our This Half-Year Financial Report is of Cann Group Limited (The group) and its subsidiaries, including Cannproducts Pty Ltd, Cannoperations Pty Ltd, Cann IP Pty Ltd, Botanitech Pty Ltd, Satipharm This Half-Year Financial Report is of Cann Group Limited (The group) and its subsidiaries, including Cannproducts Pty Ltd, Cannoperations Pty Ltd, Cann IP Pty Ltd, Botanitech Pty Ltd, Satipharm 31 January 2024 – Cann Group Limited (ASX: CAN) (Cann or the Company) is pleased to provide its December 2023 Quarterly Activities Report and Appendix 4C. com 30 August 2024 – Cann Group Limited (ASX: CAN) (Cann or the Company) today released its financial results for the financial year ending 30 June 2024. We pay our respects to Aboriginal and Torres Strait Islander cultures, and to Elders past and present. fal, sk0r2kt, sv8, 4j, kzr8dhy, f0td, ucjjo, tvaz, ukg, wcj8cw,